Home

Dr Crawford is an internationally recognized expert in prostate cancer, benign prostate hypertrophy (BPH) and other urologic cancers.

Dr. E. David Crawford, MD

The recipient of more than 95 research grants, he has conducted research in the diagnosis and treatment of prostate cancer, metastatic prostate cancer, hormone refractory prostate cancer, other prostate conditions including BPH, advanced bladder cancer and other areas of urological infections and malignancies. He has authored or coauthored over 450 published articles, contributed to nearly 100 educational books and provided thousands of educational talks for patients and physicians. In an effort to raise awareness and education about prostate health, Dr. Crawford also founded and chairs a 501c3 non-profit called the Prostate Conditions Education Council.

Targeted Focal Therapy

The next generation in prostate cancer treatment designed to preserve a patient’s quality of life by minimizing the typical side effects.

Targeted Focal Therapy is a new approach for managment of early stage, organ-confined prostate cancer. It involves freezing only the areas of cancer within the prostate and sparing the rest of the prostate. The rationale behind this approach is to preserve quality of life by minimizing collateral damage to the vital structures around the prostate. Learn more.